Citation Impact
14 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
2024 Standout
Works of Elisha Hall being referenced
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
2022
Author Peers
| Author | PHEOH | Health | Infectious Diseases | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Elisha Hall | 48 | 55 | 86 | 22 | 237 | |
| Kholoud Kahime | 286 | 2 | 76 | 21 | 342 | |
| S.C. Hsu | 3 | 47 | ||||
| Rafael Augusto Vieira | 29 | 379 | ||||
| Rei Chin How Tan | 22 | 269 | 8 | 571 | ||
| Clinton R. South | 10 | 431 |
All Works
Login with ORCID to disown or claim papers
Loading papers...